Republican skepticism and procedural hurdles under the Iran Nuclear Agreement Review Act (INARA) explain the high probability assigned to Congress rejecting any 2026 sanctions-relief package tied to Iran’s nuclear program. Following the June 2026 U.S.-Iran memorandum of understanding and subsequent talks, lawmakers from both parties demanded full text, oversight hearings, and stricter conditions such as complete dismantlement of enrichment capacity rather than temporary limits. Senate Republicans including Lindsey Graham and Tom Cotton publicly signaled that any agreement leaving enrichment pathways open would face joint resolutions of disapproval, while the 30-day INARA review window and requirement for congressional authorization of statutory sanctions relief create structural barriers to swift passage. Ongoing regional tensions and divergent U.S.-Iran interpretations of the framework have further complicated prospects for bipartisan support before year-end.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · ОновленоCongress approves Iran deal in 2026?
Congress approves Iran deal in 2026?
13% шанс
$12,413 Обс.
$12,413 Обс.
Dec 31, 2026
13% шанс
$12,413 Обс.
$12,413 Обс.
Dec 31, 2026
This market will resolve to “Yes" if the United States Congress passes a qualifying bill or resolution which, by its operative text, expresses approval regarding an agreement where the Islamic Republic of Iran and the United States are both parties by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
A qualifying bill or resolution must be a bill or joint resolution passed identically in both chambers, or a Senate resolution giving advice and consent to a treaty submitted by the President.
The resolution source for this market will be information from the United States Congress (https://congress.gov); however, a consensus of credible reporting will also be used.Republican skepticism and procedural hurdles under the Iran Nuclear Agreement Review Act (INARA) explain the high probability assigned to Congress rejecting any 2026 sanctions-relief package tied to Iran’s nuclear program. Following the June 2026 U.S.-Iran memorandum of understanding and subsequent talks, lawmakers from both parties demanded full text, oversight hearings, and stricter conditions such as complete dismantlement of enrichment capacity rather than temporary limits. Senate Republicans including Lindsey Graham and Tom Cotton publicly signaled that any agreement leaving enrichment pathways open would face joint resolutions of disapproval, while the 30-day INARA review window and requirement for congressional authorization of statutory sanctions relief create structural barriers to swift passage. Ongoing regional tensions and divergent U.S.-Iran interpretations of the framework have further complicated prospects for bipartisan support before year-end.
This market will resolve to “Yes" if the United States Congress passes a qualifying bill or resolution which, by its operative text, expresses approval regarding an agreement where the Islamic Republic of Iran and the United States are both parties by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
A qualifying bill or resolution must be a bill or joint resolution passed identically in both chambers, or a Senate resolution giving advice and consent to a treaty submitted by the President.
The resolution source for this market will be information from the United States Congress (https://congress.gov); however, a consensus of credible reporting will also be used.
A qualifying bill or resolution must be a bill or joint resolution passed identically in both chambers, or a Senate resolution giving advice and consent to a treaty submitted by the President.
The resolution source for this market will be information from the United States Congress (https://congress.gov); however, a consensus of credible reporting will also be used.
Ринок відкрито: Jun 16, 2026, 2:24 PM ET
Обсяг
$12,413Дата завершення
Jan 1, 2027Ринок відкрито
Jun 16, 2026, 2:24 PM ETResolver
0x65070BE91...This market will resolve to “Yes" if the United States Congress passes a qualifying bill or resolution which, by its operative text, expresses approval regarding an agreement where the Islamic Republic of Iran and the United States are both parties by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
A qualifying bill or resolution must be a bill or joint resolution passed identically in both chambers, or a Senate resolution giving advice and consent to a treaty submitted by the President.
The resolution source for this market will be information from the United States Congress (https://congress.gov); however, a consensus of credible reporting will also be used.Republican skepticism and procedural hurdles under the Iran Nuclear Agreement Review Act (INARA) explain the high probability assigned to Congress rejecting any 2026 sanctions-relief package tied to Iran’s nuclear program. Following the June 2026 U.S.-Iran memorandum of understanding and subsequent talks, lawmakers from both parties demanded full text, oversight hearings, and stricter conditions such as complete dismantlement of enrichment capacity rather than temporary limits. Senate Republicans including Lindsey Graham and Tom Cotton publicly signaled that any agreement leaving enrichment pathways open would face joint resolutions of disapproval, while the 30-day INARA review window and requirement for congressional authorization of statutory sanctions relief create structural barriers to swift passage. Ongoing regional tensions and divergent U.S.-Iran interpretations of the framework have further complicated prospects for bipartisan support before year-end.
This market will resolve to “Yes" if the United States Congress passes a qualifying bill or resolution which, by its operative text, expresses approval regarding an agreement where the Islamic Republic of Iran and the United States are both parties by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
A qualifying bill or resolution must be a bill or joint resolution passed identically in both chambers, or a Senate resolution giving advice and consent to a treaty submitted by the President.
The resolution source for this market will be information from the United States Congress (https://congress.gov); however, a consensus of credible reporting will also be used.
A qualifying bill or resolution must be a bill or joint resolution passed identically in both chambers, or a Senate resolution giving advice and consent to a treaty submitted by the President.
The resolution source for this market will be information from the United States Congress (https://congress.gov); however, a consensus of credible reporting will also be used.
Обсяг
$12,413Дата завершення
Jan 1, 2027Ринок відкрито
Jun 16, 2026, 2:24 PM ETResolver
0x65070BE91...Republican skepticism and procedural hurdles under the Iran Nuclear Agreement Review Act (INARA) explain the high probability assigned to Congress rejecting any 2026 sanctions-relief package tied to Iran’s nuclear program. Following the June 2026 U.S.-Iran memorandum of understanding and subsequent talks, lawmakers from both parties demanded full text, oversight hearings, and stricter conditions such as complete dismantlement of enrichment capacity rather than temporary limits. Senate Republicans including Lindsey Graham and Tom Cotton publicly signaled that any agreement leaving enrichment pathways open would face joint resolutions of disapproval, while the 30-day INARA review window and requirement for congressional authorization of statutory sanctions relief create structural barriers to swift passage. Ongoing regional tensions and divergent U.S.-Iran interpretations of the framework have further complicated prospects for bipartisan support before year-end.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено
Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання